Andorsky, David J.

Asciminib in Newly Diagnosed Chronic Myeloid Leukemia

Hochhaus, A., Wang, J., Kim, D.-W., Kim, D. D. H., Mayer, J., Goh, Y.-T., le Coutre, P., Takahashi, N., Kim, I., Etienne, G., et al. (2024) · New England Journal of Medicine

Chronic Myeloid Leukemia TreatmentsChronic Lymphocytic Leukemia Research

Cited by 171

Acceptability, Feasibility, and Efficacy Potential of a Multimodal Acceptance and Commitment Therapy Intervention to Address Psychosocial and Advance Care Planning Needs among Anxious and Depressed Adults with Metastatic Cancer.

Arch, J. J., Fishbein, J. N., Ferris, M. C., Mitchell, J. L., Levin, M. E., Slivjak, E. T., Andorsky, D. J., & Kutner, J. S. (2020) · Journal of Palliative Medicine

Mindfulness and Compassion InterventionsCancer survivorship and care

Cited by 48

Randomized trial of acceptance and commitment therapy for anxious cancer survivors in community clinics: Outcomes and moderators.

Arch, J. J., Mitchell, J. L., Genung, S. R., Judd, C. M., Andorsky, D. J., Bricker, J. B., & Stanton, A. L. (2021) · Journal of Consulting and Clinical Psychology

Cancer survivorship and careMindfulness and Compassion Interventions

Cited by 43

Anxiety and Depression in Metastatic Cancer: A Critical Review of Negative Impacts on Advance Care Planning and End-of-Life Decision Making With Practical Recommendations

Arch, J. J., Bright, E. E., Finkelstein, L. B., Fink, R. M., Mitchell, J. L., Andorsky, D. J., & Kutner, J. S. (2023) · JCO Oncology Practice

Palliative Care and End-of-Life IssuesPalliative and Oncologic Care

Cited by 25

A randomized controlled trial of a group acceptance-based intervention for cancer survivors experiencing anxiety at re-entry ('Valued Living'): Study protocol

Arch, J. J., Mitchell, J. L., Genung, S. R., Fisher, R., Andorsky, D. J., & Stanton, A. L. (2019) · BMC Cancer

Cancer survivorship and careMindfulness and Compassion Interventions

Cited by 20

Completed induction phase analysis of MAGNIFY: phase 3b study of lenalidomide + rituximab (R 2) followed by maintenance in relapsed/refractory indolent non-Hodgkin lymphoma

Lansigan, F., Andorsky, D. J., Coleman, M., Yacoub, A., Melear, J., Fanning, S., Kolibaba, K. S., Reynolds, C. M., Nowakowski, G. S., Gharibo, M., et al. (2021) · Blood

Lymphoma Diagnosis and TreatmentChronic Lymphocytic Leukemia Research

Cited by 14

A randomized controlled trial of a multi-modal palliative care intervention to promote advance care planning and psychological well-being among adults with advanced cancer: study protocol.

Arch, J. J., Mitchell, J. L., Schmiege, S. J., Levin, M. E., Genung, S. R., Nealis, M. S., Fink, R. M., Bright, E. E., Andorsky, D. J., & Kutner, J. S. (2022) · BMC Palliative Care

Palliative Care and End-of-Life IssuesPalliative and Oncologic Care

Cited by 8

Asciminib (ASC) Demonstrates Favorable Safety and Tolerability Compared with Each Investigator-Selected Tyrosine Kinase Inhibitor (IS TKI) in Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP) in the Pivotal Phase 3 ASC4FIRST Study

Cortes, J. E., Hochhaus, A., Hughes, T. P., Wang, J., Kim, D.-W., Kim, D. D. H., Mayer, J., Goh, Y. T., le Coutre, P., Etienne, G., et al. (2024) · Blood

Chronic Myeloid Leukemia TreatmentsChronic Lymphocytic Leukemia Research

Cited by 7